OncLive® On Air

S10 Ep13: FDA Approval Insights: Enfortumab Vedotin Plus Pembrolizumab in Locally Advanced/Metastatic Urothelial Carcinoma

Feb 12, 2024
Ask episode
Chapters
Transcript
Episode notes